Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients.
Clinical characteristics and treatment responses were studied in 130 patients with burning mouth syndrome (BMS). Most patients were postmenopausal women, and the tongue was the most frequently afflicted site. Although 39% of the patients complained of dry mouth, no causative factors were evident. Therefore BMS is assumed to be a functional disorder. This was at least partially confirmed because the most effective management was in response to mood-altering drugs. From our data BMS appears to be a chronic condition with variations in symptoms among patients and without a predictable endpoint.
Gorsky
M
M
Division of Oral Medicine, University of California, San Francisco.
Silverman
S
S
Chinn
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000639:Amitriptyline / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002054:Burning Mouth Syndrome / Q000188:drug therapy* / Q000523:psychology; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010862:Pilocarpine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014060:Tongue Diseases / Q000188:drug therapy; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000627:therapeutic use
D000935:Antifungal Agents; D010862:Pilocarpine; D014803:Vitamin B Complex; D000639:Amitriptyline; D002707:Chlordiazepoxide; D003975:Diazepam; D011241:Prednisone